News Tag: research results
Three Week Hypo-fractionated Whole Breast Irradiation (WBI) with Concurrent Boost is not Inferior to Conventional WBI with a Sequential Boost Following Lumpectomy for Patients with High-Risk, Early-Stage Breast Cancer
Read More
The Addition of Stereotactic Body Radiation Therapy (SBRT) to Sorafenib in Patients with Advanced Hepatocellular Carcinoma Improves Overall Survival
Read More
Oncology Tube Conducts Interviews on NRG Oncology Research Presented During the 2022 ASCO Annual Meeting: NRG-HN002 and NRG-GI008
Read More
NRG Oncology NCORP Trial of Hippocampal Avoidance for Small Cell Lung Cancer Patients Receiving Prophylactic Cranial Irradiation Reaches Accrual Goal
Read More
PSA-Based Endpoints Should Not Be Used as Surrogate Endpoints for Overall Survival in Men with Recurrent Prostate Cancer at this Time
Read More
Joint Final Report of Phase III trials Demonstrate Positive Outcomes from Combination of PCV Chemotherapy and RT in Patients with Anaplastic Oligodendroglial Tumors
Read More
Additional Taxane Maintenance Therapy Does Not Successfully Improve Overall Survival for Women with Advanced Ovarian, Peritoneal, and Tubal Cancers
Read More
NRG Oncology Trial Indicates Using Atezolizumab with Chemoradiation is Safe and Demonstrates Signs of Immune Activation in Women with Cervical Cancer
Read More
HRR Mutational Status Prognostic of Survival Outcomes in Biomarker Analysis of NRG Oncology Trial for Women with Recurrent Platinum-Sensitive Ovarian Cancer
Read More
NRG Oncology Trial Results Indicate Trametinib Should Represent the New Standard of Care for Women with Recurrent Low-Grade Serous Ovarian Cancer
Read More